ArticleCancer biology & therapy2017

Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma.

Caitlin D May et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.